Jesse Wayne Hall's Insider Trades & SAST Disclosures

Jesse Wayne Hall's most recent trade in Aclaris Therapeutics Inc was a trade of 36,375 Common Stock done . Disclosure was reported to the exchange on May 1, 2026.

Share

Note

This is a custom search result for pattern Jesse Wayne Hall.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Aclaris Therapeutics Inc	Jesse Wayne Hall	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 May 2026	36,375	36,375 (0%)	0%		-	Common Stock
Aclaris Therapeutics Inc	Jesse Wayne Hall	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 May 2026	36,375	109,125	-		-	Restricted Stock Units
Aclaris Therapeutics Inc	Jesse Wayne Hall	Chief Medical Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.41 per share.	01 May 2026	9,330	27,045 (0%)	0%	4.4	41,145	Common Stock
Aclaris Therapeutics Inc	Jesse Wayne Hall	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Feb 2026	343,300	343,300	-		-	Employee Stock Option (Right to Buy)
Aclaris Therapeutics Inc	Jesse Wayne Hall	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Feb 2026	98,100	98,100	-		-	Restricted Stock Units
Aclaris Therapeutics Inc	Jesse Wayne Hall	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 May 2025	510,000	510,000	-		-	Employee Stock Option (right to buy)
Aclaris Therapeutics Inc	Jesse Wayne Hall	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 May 2025	145,500	145,500	-		-	Restricted Stock Units

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades